Paul Singer Cor Medix Inc. Transaction History
Elliott Investment Management L.P.
- $18.8 Billion
- Q3 2024
A detailed history of Paul Singer (Elliott Investment Management L.P.) transactions in Cor Medix Inc. stock. As of the latest transaction made, Elliott Investment Management L.P. holds 1,550,523 shares of CRMD stock, worth $12.9 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,550,523
Previous 1,550,523
-0.0%
Holding current value
$12.9 Million
Previous $6.71 Million
86.62%
% of portfolio
0.07%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding CRMD
# of Institutions
105Shares Held
17.4MCall Options Held
134KPut Options Held
441K-
Black Rock Inc. New York, NY3.55MShares$29.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.07MShares$25.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.28MShares$10.7 Million0.0% of portfolio
-
State Street Corp Boston, MA1.23MShares$10.2 Million0.0% of portfolio
-
Voya Investment Management LLC Atlanta, GA712KShares$5.93 Million0.01% of portfolio
About CorMedix Inc.
- Ticker CRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,208,200
- Market Cap $343M
- Description
- CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...